On 18 December 2019, our new EUROIMMUN subsidiary in Japan was officially founded after one year of hard work, intensive planning and structuring. Head of this new subsidiary is Cagla Egretaud, who has been working at EUROIMMUN for 20 years. The idea to jointly establish a new subsidiary in Japan, one of the world’s largest […]
Five years ago, the ICAP initiative on harmonisation and standardisation in the nomenclature of HEp-2 IFA patterns was implemented at the International Workshop on Autoantibodies and Autoimmunity (IWAA) in São Paulo, Brazil. Luis E. C. Andrade, professor at the Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, has been involved from the
This autumn, cases of West Nile virus and Zika virus infections due to transmission by infected mosquitoes have occurred locally for the first time in Germany and France. These cases of locally acquired infections are also named autochthonous cases. Several infectious agents, some of them just newly identified, have spread globally over the past years,
Recently, a new law on measles vaccination has been passed in Germany. As of March 2020, all children in Germany from the age of one year must present proof of their vaccination against measles, as recommended by the Standing Committee on Vaccination (StiKO), before their admission into crèche, kindergarten, school or other childcare, such as
Recently, a very interesting review article on the diagnostics of bullous dermatoses has been published in Frontiers of Immunology, a peer-reviewed journal. The publication is authored by EUROIMMUN scientists, who were invited to write an expert review article on this important topic. Over the past few years, EUROIMMUN has become a true leader in this
